Form 8-K - Current report:
SEC Accession No. 0001104659-14-016699
Filing Date
2014-03-06
Accepted
2014-03-06 09:35:45
Documents
7
Period of Report
2014-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-7331_18k.htm 8-K 31991
2 EX-1.1 a14-7331_1ex1d1.htm EX-1.1 223376
3 EX-5.1 a14-7331_1ex5d1.htm EX-5.1 13576
4 EX-99.1 a14-7331_1ex99d1.htm EX-99.1 9315
5 EX-99.2 a14-7331_1ex99d2.htm EX-99.2 11454
6 GRAPHIC g73311kki001.jpg GRAPHIC 2647
7 GRAPHIC g73311moi001.jpg GRAPHIC 4790
  Complete submission text file 0001104659-14-016699.txt   301406
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Filer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35890 | Film No.: 14671650
SIC: 2834 Pharmaceutical Preparations